For patients with chronic ischemic heart failure, transendocardial injection of autologous bone marrow mononuclear cells (BMCs) is not associated with improved prespecified outcomes.
Sign in with your MPR account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH A MPR ACCOUNT
Enter your MPR registration email address to receive a new password.